Cargando…

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?

Antithrombin (AT) has been used for over 25 years to successfully treat disseminated intravascular coagulation (DIC). A four-day AT therapy in patients with DIC in the KyberSept trial has been related to a clear survival benefit in patients not receiving concomitant heparin. Gonano and coworkers per...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Johannes N, Schick, Kerstin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151912/
https://www.ncbi.nlm.nih.gov/pubmed/17331267
http://dx.doi.org/10.1186/cc5156